Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Callahan

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Physics and Imaging in Radiation Oncology|April 25, 2022
Quantitative assessment of ventilation-perfusion relationships with gallium-68 positron emission tomography/computed tomography imaging in lung cancer patientsZhuorui Li, Pierre-Yves Le Roux, Jason Callahan, et al.
Radiation Oncology (London, England)|November 27, 2014
Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CTPrice Jackson, Farshad Foroudi, Daniel Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2015
15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell CarcinomaKeelan Byrne, Shankar Siva, Lori Chait, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown PrimaryTharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.
Radiation Oncology (London, England)|December 17, 2014
Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumesJason Callahan, Tomas Kron, Shankar Siva, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2017
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2015
Incremental diagnostic utility of gastric distension FDG PET/CTPierre-Yves Le Roux, Cuong P Duong, Carlos S Cabalag, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CTJason Callahan, Michael S Hofman, Shankar Siva, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 14, 2021
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinomaLuke S McLean, Karda Cavanagh, Rodney J Hicks, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Physics and Imaging in Radiation Oncology|April 25, 2022
Quantitative assessment of ventilation-perfusion relationships with gallium-68 positron emission tomography/computed tomography imaging in lung cancer patientsZhuorui Li, Pierre-Yves Le Roux, Jason Callahan, et al.
Radiation Oncology (London, England)|November 27, 2014
Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CTPrice Jackson, Farshad Foroudi, Daniel Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2015
15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell CarcinomaKeelan Byrne, Shankar Siva, Lori Chait, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown PrimaryTharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.
Radiation Oncology (London, England)|December 17, 2014
Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumesJason Callahan, Tomas Kron, Shankar Siva, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2017
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2015
Incremental diagnostic utility of gastric distension FDG PET/CTPierre-Yves Le Roux, Cuong P Duong, Carlos S Cabalag, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CTJason Callahan, Michael S Hofman, Shankar Siva, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 14, 2021
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinomaLuke S McLean, Karda Cavanagh, Rodney J Hicks, et al.
Pageof 9